|
1
|
Spreafico A, Frediani B, Francucci CM,
Capperucci C, Chellini F and Galeazzi M: Role of apoptosis in
osteoporosis induced by glucocorticoids. J Endocrinol Invest. 31
Suppl 7:S22–S27. 2008.
|
|
2
|
Yongtao Z, Kunzheng W, Jingjing Z, Hu S,
Jianqiang K, Ruiyu L and Chunsheng W: Glucocorticoids activate the
local renin-angiotensin system in bone: Possible mechanism for
glucocorticoid-induced osteoporosis. Endocrine. 47:598–608. 2014.
View Article : Google Scholar
|
|
3
|
Hofbauer LC, Gori F, Riggs BL, Lacey DL,
Dunstan CR, Spelsberg TC and Khosla S: Stimulation of
osteoprotegerin ligand and inhibition of osteoprotegerin production
by glucocorticoids in human osteoblastic lineage cells: Potential
paracrine mechanisms of glucocorticoid-induced osteoporosis.
Endocrinology. 140:4382–4389. 1999. View Article : Google Scholar
|
|
4
|
Shaker JL and Lukert BP: Osteoporosis
associated with excess glucocorticoids. Endocrinol Metab Clin North
Am. 34:341–356. 2005. View Article : Google Scholar
|
|
5
|
Li C, Li Q, Mei Q and Lu T:
Pharmacological effects and pharmacokinetic properties of icariin,
the major bioactive component in Herba Epimedii. Life Sci.
126:57–68. 2015. View Article : Google Scholar
|
|
6
|
Zhang X, Liu T, Huang Y, Wismeijer D and
Liu Y: Icariin: Does it have an osteoinductive potential for bone
tissue engineering? Phytother Res. 28:498–509. 2014. View Article : Google Scholar
|
|
7
|
Yang L, Yu Z, Qu H and Li M: Comparative
effects of hispidulin, genistein, and icariin with estrogen on bone
tissue in ovariectomized rats. Cell Biochem Biophys. 70:485–490.
2014. View Article : Google Scholar
|
|
8
|
Liu M, Zhong C, He RX and Chen LF: Icariin
associated with exercise therapy is an effective treatment for
postmenopausal osteoporosis. Chin Med J (Engl). 125:1784–1789.
2012.
|
|
9
|
Feng R, Feng L, Yuan Z, Wang D, Wang F,
Tan B, Han S, Li T, Li D and Han Y: Icariin protects against
glucocorticoid-induced osteoporosis in vitro and prevents
glucocorticoid-induced osteocyte apoptosis in vivo. Cell Biochem
Biophys. 67:189–197. 2013. View Article : Google Scholar
|
|
10
|
Zhang G, Qin L and Shi Y:
Epimedium-derived phytoestrogen flavonoids exert beneficial effect
on preventing bone loss in late postmenopausal women: A 24-month
randomized, double-blind and placebo-controlled trial. J Bone Miner
Res. 22:1072–1079. 2007. View Article : Google Scholar
|
|
11
|
Song L, Zhao J, Zhang X, Li H and Zhou Y:
Icariin induces osteoblast proliferation, differentiation and
mineralization through estrogen receptor-mediated ERK and JNK
signal activation. Eur J Pharmacol. 714:15–22. 2013. View Article : Google Scholar
|
|
12
|
Wu Y, Xia L, Zhou Y, Xu Y and Jiang X:
Icariin induces osteogenic differentiation of bone mesenchymal stem
cells in a MAPK-dependent manner. Cell Prolif. 48:375–384. 2015.
View Article : Google Scholar
|
|
13
|
Sun P, Liu Y, Deng X, Yu C, Dai N, Yuan X,
Chen L, Yu S, Si W, Wang X, et al: An inhibitor of cathepsin K,
icariin suppresses cartilage and bone degradation in mice of
collagen-induced arthritis. Phytomedicine. 20:975–979. 2013.
View Article : Google Scholar
|
|
14
|
Skoumal M, Haberhauer G, Kolarz G, Hawa G,
Woloszczuk W, Klingler A, Varga F and Klaushofer K: The imbalance
between osteoprotegerin and cathepsin K in the serum of patients
with longstanding rheumatoid arthritis. Rheumatol Int. 28:637–641.
2008. View Article : Google Scholar
|
|
15
|
Lewiecki EM: Odanacatib, a cathepsin K
inhibitor for the treatment of osteoporosis and other skeletal
disorders associated with excessive bone remodeling. IDrugs.
12:799–809. 2009.
|
|
16
|
Bone HG, McClung MR, Roux C, Recker RR,
Eisman JA, Verbruggen N, Hustad CM, DaSilva C, Santora AC and Ince
BA: Odanacatib, a cathepsin-K inhibitor for osteoporosis: A
two-year study in postmenopausal women with low bone density. J
Bone Miner Res. 25:937–947. 2010.
|
|
17
|
Dole NS and Delany AM: MicroRNA variants
as genetic determinants of bone mass. Bone. 84:57–68. 2016.
View Article : Google Scholar
|
|
18
|
Kagiya T: MicroRNAs and osteolytic bone
metastasis: The roles of microRNAs in tumor-induced osteoclast
differentiation. J Clin Med. 4:1741–1752. 2015. View Article : Google Scholar :
|
|
19
|
Xia Z, Chen C, Chen P, Xie H and Luo X:
MicroRNAs and their roles in osteoclast differentiation. Front Med.
5:414–419. 2011. View Article : Google Scholar
|
|
20
|
Arfat Y, Xiao WZ, Ahmad M, Zhao F, Li DJ,
Sun YL, Hu L, Zhihao C, Zhang G, Iftikhar S, et al: Role of
microRNAs in osteoblasts differentiation and bone disorders. Curr
Med Chem. 22:748–758. 2015. View Article : Google Scholar
|
|
21
|
Gamez B, Rodriguez-Carballo E and Ventura
F: MicroRNAs and post-transcriptional regulation of skeletal
development. J Mol Endocrinol. 52:R179–R197. 2014. View Article : Google Scholar
|
|
22
|
Taipaleenmäki H, Hokland Bjerre L, Chen L,
Kauppinen S and Kassem M: Mechanisms in endocrinology: micro-RNAs:
Targets for enhancing osteoblast differentiation and bone
formation. Eur J Endocrinol. 166:359–371. 2012. View Article : Google Scholar
|
|
23
|
Cuetara BL, Crotti TN, O'Donoghue AJ and
McHugh KP: Cloning and characterization of osteoclast precursors
from the RAW264.7 cell line. In Vitro Cell Dev Biol Anim.
42:182–188. 2006. View Article : Google Scholar :
|
|
24
|
Parfitt AM, Drezner MK, Glorieux FH, Kanis
JA, Malluche H, Meunier PJ, Ott SM and Recker RR: Bone
histomorphometry: Standardization of nomenclature, symbols and
units. Report of the ASBMR Histomorphometry Nomenclature Committee.
J Bone Miner Res. 2:595–610. 1987. View Article : Google Scholar
|
|
25
|
Turner CH and Burr DB: Basic biomechanical
measurements of bone: A tutorial. Bone. 14:595–608. 1993.
View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Jensen PR, Andersen TL, Hauge EM,
Bollerslev J and Delaisse JM: A joined role of canopy and reversal
cells in bone remodeling-lessons from glucocorticoid-induced
osteoporosis. Bone. 73:16–23. 2014. View Article : Google Scholar
|
|
28
|
Tamura Y, Kawao N, Yano M, Okada K,
Okumoto K, Chiba Y, Matsuo O and Kaji H: Role of plasminogen
activator inhibitor-1 in glucocorticoid-induced diabetes and
osteopenia in mice. Diabetes. 64:2194–2206. 2015. View Article : Google Scholar
|
|
29
|
Panwar P, Soe K, Guido RV, Bueno RV,
Delaisse JM and Bromme D: A novel approach to inhibit bone
resorption: Exosite inhibitors against cathepsin K. Br J Pharmacol.
173:396–410. 2016. View Article : Google Scholar
|
|
30
|
Helali AM, Iti FM and Mohamed IN:
Cathepsin K inhibitors: A novel target but promising approach in
the treatment of osteoporosis. Curr Drug Targets. 14:1591–1600.
2013. View Article : Google Scholar
|
|
31
|
Brixen K, Chapurlat R, Cheung AM, Keaveny
TM, Fuerst T, Engelke K, Recker R, Dardzinski B, Verbruggen N,
Ather S, et al: Bone density, turnover, and estimated strength in
postmenopausal women treated with odanacatib: A randomized trial. J
Clin Endocrinol Metab. 98:571–580. 2013. View Article : Google Scholar
|
|
32
|
Fan JJ, Cao LG, Wu T, Wang DX, Jin D,
Jiang S, Zhang ZY, Bi L and Pei GX: The dose-effect of icariin on
the proliferation and osteogenic differentiation of human bone
mesenchymal stem cells. Molecules. 16:10123–10133. 2011. View Article : Google Scholar
|
|
33
|
Cui J, Zhu M, Zhu S, Wang G, Xu Y and Geng
D: Inhibitory effect of icariin on Ti-induced inflammatory
osteoclastogenesis. J Surg Res. 192:447–453. 2014. View Article : Google Scholar
|
|
34
|
Li T, Li H, Li T, Fan J, Zhao RC and Weng
X: MicroRNA expression profile of dexamethasone-induced human bone
marrow-derived mesenchymal stem cells during osteogenic
differentiation. J Cell Biochem. 115:1683–1691. 2014. View Article : Google Scholar
|
|
35
|
Ko JY, Chuang PC, Chen MW, Ke HC, Wu SL,
Chang YH, Chen YS and Wang FS: MicroRNA-29a ameliorates
glucocorticoid-induced suppression of osteoblast differentiation by
regulating β-catenin acetylation. Bone. 57:468–475. 2013.
View Article : Google Scholar
|
|
36
|
Wang FS, Chuang PC, Lin CL, Chen MW, Ke
HJ, Chang YH, Chen YS, Wu SL and Ko JY: MicroRNA-29a protects
against glucocorticoid-induced bone loss and fragility in rats by
orchestrating bone acquisition and resorption. Arthritis Rheum.
65:1530–1540. 2013. View Article : Google Scholar
|
|
37
|
Li H, Li T, Fan J, Li T, Fan L, Wang S,
Weng X, Han Q and Zhao RC: miR-216a rescues dexamethasone
suppression of osteogenesis, promotes osteoblast differentiation
and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT
pathway. Cell Death Differ. 22:1935–1945. 2015. View Article : Google Scholar :
|
